Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signaling
Abstract Oncostatin M (OSM) has pleiotropic effects on various inflammatory diseases, including kidney stone disease. The prevalence of kidney stones has increased worldwide, despite recent therapeutic advances, due to its high recurrence rate, suggesting the importance of prevention of repeated rec...
Saved in:
| Main Authors: | Ryusuke Deguchi, Tadasuke Komori, Shimpei Yamashita, Tomoko Hisaoka, Mizuki Kajimoto, Yasuo Kohjimoto, Isao Hara, Yoshihiro Morikawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-80411-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapidly Progressing Renal Cell Carcinoma With Unexpected Inferior Vena Cava Tumor Thrombus
by: Sohei Iwagami, et al.
Published: (2025-05-01) -
Pembrolizumab Plus Lenvatinib for Metastatic Renal Cell Carcinoma in a Patient on Hemodialysis
by: Shimpei Yamashita, et al.
Published: (2025-05-01) -
Oncostatin M enhances the lengthening of sensory nerves and skin hypersensitivity
by: Chie Ishikawa, et al.
Published: (2025-07-01) -
Drug Repurposing to Inhibit Oncostatin M in Crohn’s Disease
by: Faranak Bahramimehr, et al.
Published: (2025-04-01) -
Transplantation of Horseshoe Kidney from Living, Genetically Unrelated Donor
by: Kazuro Kikkawa, et al.
Published: (2015-01-01)